Arcus Biosciences (RCUS) Operating Expenses (2017 - 2025)
Historic Operating Expenses for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $168.0 million.
- Arcus Biosciences' Operating Expenses rose 980.39% to $168.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $615.0 million, marking a year-over-year increase of 585.2%. This contributed to the annual value of $588.0 million for FY2024, which is 2866.52% up from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Operating Expenses is $168.0 million, which was up 980.39% from $168.0 million recorded in Q2 2025.
- In the past 5 years, Arcus Biosciences' Operating Expenses registered a high of $168.0 million during Q2 2025, and its lowest value of $73.6 million during Q4 2021.
- In the last 5 years, Arcus Biosciences' Operating Expenses had a median value of $112.0 million in 2023 and averaged $118.5 million.
- As far as peak fluctuations go, Arcus Biosciences' Operating Expenses surged by 17266.33% in 2021, and later plummeted by 683.23% in 2025.
- Over the past 5 years, Arcus Biosciences' Operating Expenses (Quarter) stood at $73.6 million in 2021, then soared by 46.74% to $108.0 million in 2022, then grew by 12.96% to $122.0 million in 2023, then grew by 5.74% to $129.0 million in 2024, then skyrocketed by 30.23% to $168.0 million in 2025.
- Its Operating Expenses stands at $168.0 million for Q3 2025, versus $168.0 million for Q2 2025 and $150.0 million for Q1 2025.